Gombotz Hans
Department for Anesthesiology and Intensive Care Medicine, General Hospital Linz, Austria.
Transfus Med Hemother. 2012 Apr;39(2):67-72. doi: 10.1159/000337183. Epub 2012 Mar 8.
Patient Blood Management (PBM) describes an evidence-based, multidisciplinary therapeutic approach. Its focus is on the treatment of the individual patient and as such comprises transfusion therapy and pharmacotherapy. Furthermore, the applicability of PBM is not limited to the perioperative setting but is applicable also to other therapeutic measures and disciplines where significant blood loss is known to occur and where transfusion of blood products is part of the established treatment. PBM is fundamentally based on 3 pillars: (1) optimization of the (preoperative) erythrocyte volume, (2) reduction of diagnostic, therapeutic, or intraoperative blood loss, and (3) increasing individual tolerance towards anemia and accurate blood transfusion triggers. PBM primarily identifies patients at risk of transfusion and provides a management plan aimed at reducing or eliminating the risk of anemia and the need for allogeneic transfusion, thus reducing the inherent risks, inventory pressures, and the escalating costs associated with transfusion.
患者血液管理(PBM)描述了一种基于证据的多学科治疗方法。其重点在于个体患者的治疗,因此包括输血治疗和药物治疗。此外,PBM的适用性不仅限于围手术期,还适用于已知会发生大量失血且输血制品是既定治疗一部分的其他治疗措施和学科。PBM基本基于三个支柱:(1)优化(术前)红细胞容量,(2)减少诊断、治疗或术中失血,以及(3)提高个体对贫血的耐受性和精确的输血触发指标。PBM主要识别有输血风险的患者,并提供旨在降低或消除贫血风险和异体输血需求的管理计划,从而降低与输血相关的固有风险、库存压力和不断攀升的成本。